Journal of Applied Research on Children: Informing Policy for
Children at Risk
Volume 10
Issue 2 Vaccinations in Texas: Lessons Learned
for Evidence-Based Practices for Child Health

Article 8

2019

Implementation costs of a multi-component program to increase
human papillomavirus (HPV) vaccination in a network of pediatric
clinics
Jarrod S. Eska
University of Texas Health Science Center at Houston, jseska@mdanderson.org

David R. Lairson
University of Texas Health Science Center at Houston, david.r.lairson@uth.tmc.edu

Lara S. Savas
University of Texas Health Science Center at Houston, Lara.Staub@uth.tmc.edu

Ross Shegog
University of Texas Health Science Center at Houston, ross.shegog@uth.tmc.edu

C Mary Healy
Baylor College of Medicine, chealy@bcm.edu
Follow this and additional works at: https://digitalcommons.library.tmc.edu/childrenatrisk
See next page for additional authors

Recommended Citation
Eska, Jarrod S.; Lairson, David R.; Savas, Lara S.; Shegog, Ross; Healy, C Mary; Spinner, Stanley W. MD;
Fernandez, Maria E.; and Vernon, Sally W. (2019) "Implementation costs of a multi-component program to
increase human papillomavirus (HPV) vaccination in a network of pediatric clinics," Journal of Applied
Research on Children: Informing Policy for Children at Risk: Vol. 10 : Iss. 2 , Article 8.
Available at: https://digitalcommons.library.tmc.edu/childrenatrisk/vol10/iss2/8

The Journal of Applied Research on Children is brought
to you for free and open access by CHILDREN AT RISK at
DigitalCommons@The Texas Medical Center. It has a "cc
by-nc-nd" Creative Commons license" (Attribution NonCommercial No Derivatives) For more information, please
contact digitalcommons@exch.library.tmc.edu

Implementation costs of a multi-component program to increase human
papillomavirus (HPV) vaccination in a network of pediatric clinics
Acknowledgements
The study was supported by two grants from the Cancer Prevention and Research Institute of Texas
(RP150014 and PP140183).

Authors
Jarrod S. Eska, David R. Lairson, Lara S. Savas, Ross Shegog, C Mary Healy, Stanley W. Spinner MD, Maria
E. Fernandez, and Sally W. Vernon

This article is available in Journal of Applied Research on Children: Informing Policy for Children at Risk:
https://digitalcommons.library.tmc.edu/childrenatrisk/vol10/iss2/8

Eska et al.: Implementation costs to increase HPV vaccination in pediatric clinics

INTRODUCTION
An estimated 79 million Americans are infected with the human
papillomavirus (HPV). An additional 14 million people are infected each
year, and most sexually active people will contract HPV at some point in
their life.1 Every year there are over 33,000 cancers caused by HPV, most
commonly cervical cancer in women and oropharyngeal cancers in men.2
In 2006, the Food and Drug Administration (FDA) approved a
vaccine that was subsequently recommended for routine vaccination by the
Advisory Committee for Immunization Practices (ACIP) for adolescent girls
and later boys at ages 11 and 12 years. Vaccination at this age is
recommended because the immune response is stronger at younger ages
and because the vaccine should be administered before the initiation of
sexual activity and exposure to HPV. It is also recommended for females
ages 13-26 and males ages 13-21 not previously vaccinated.3,4 Awareness
of the vaccine has increased since its introduction to the market. However,
as of 2017, 39% of adolescent males and females were up to date with the
vaccine series by age 13 and 49% of 13- to 17-year-olds were up to date
compared to the 80% completion goal established by Healthy People
2020.5,6
Missed clinical opportunities are reported as the primary factor for
not achieving higher rates of HPV vaccination.7 Parents have indicated that
the most important determinants of having their child vaccinated are having
their healthcare provider recommend it, talking with a doctor, having time to
discuss it, and visiting their healthcare provider in the past year.8–13 Studies
have corroborated this finding by showing that receiving a strong
recommendation from their healthcare provider was the most important
factor in parents’ decision to vaccinate their child.14,15 Parents’ lack of
information has been cited as a key barrier, and perceived satisfaction in
the quality of information they receive is associated with uptake of the
vaccine.16–18
Researchers at the University of Texas Health Science Center at
Houston (UTHealth) and Baylor College of Medicine (BCM) in collaboration
with Texas Children’s Pediatrics (TCP) implemented evidence-based
strategies to increase HPV vaccination rates in the Houston, Texas area.
This multicomponent program consisted of provider assessment and
feedback, provider reminders, and provider education components to
increase provider recommendation of the vaccine, and parent education
and reminders to provide quality information about HPV, HPV vaccination,
and vaccination recommendations.
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The purpose of this analysis was to examine costs, from the
clinic/network perspective, associated with program implementation in a
large pediatric clinic network with a sensitivity analysis examining effects of
varying program implementation. As providers and healthcare
organizations consider vaccination initiatives, it is important for decision
makers to understand costs associated with implementing and recruiting
patients/guardians for various components of these programs in their
respective organizations.
METHODS
Study Description

This prospective cost analysis was conducted alongside the delivery of a
multicomponent program to increase HPV vaccination in a network of
pediatric clinics in a 5-county area around Houston from October 2015
through February 2018. The Adolescent Vaccination Project (AVP)
consisted of four sequentially implemented components: assessment and
feedback, provider education, provider/parent reminders, and parent
education.
The TCP network includes 51 pediatric primary care clinics affiliated
with Texas Children’s Hospital and serves approximately 20% of the greater
Houston metropolitan area pediatric population with over 200 physicians
and 800 clinical staff. The average clinic has 19 clinical staff including
physicians, nurse practitioners, nurses, and medical assistants. Over
152,000 unique patients between the ages of 11 and 17 were eligible to
receive the HPV vaccine during the study period.
Immunization champions serving as liaisons between researchers
and their respective clinic distributed tailored assessment and feedback
(A&F) reports highlighting individual physician and aggregate clinic
vaccination rates. The reports allowed providers to compare their
vaccination rates with other clinics as well as national goals. One year after
A&F implementation, the provider education program was introduced to all
clinical staff. We developed a one-hour online continuing education (CE)
session based on a preliminary needs assessment to relay the most current
information regarding HPV and HPV vaccination and provide best practices
for communicating with parents addressing potential barriers to
immunization. The final system-level program was an automated reminder
system for both providers and parents. Providers received reminders
through the electronic health record (EHR) indicating if a patient was due or
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overdue for a dose of HPV vaccine. Parents received similar reminders
through the network’s patient portal.
In addition to system-level strategies, parents were recruited to
participate in a parent education program based on clinic randomization. A
mobile application (app) specific to TCP presented several modules
describing HPV, HPV vaccine, testimonials from network providers and
parents, and tools to schedule their next appointment and receive
appointment reminders through alerts on their mobile device.
Cost Estimation

In 2018, we used micro-costing at the clinic level to estimate program fixed
and variable costs. This detailed and time-intensive method provides the
most precise estimate of actual costs compared to gross costing, which
depends on the price of services provided in the healthcare market and
which may not be available for new services.19
Fixed costs were incurred prior to service delivery. These comprised
contract services from third-party vendors to 1) implement automated EHR
vaccination reminders for providers and parents, and 2) produce a networktailored mobile application to educate parents on HPV and HPV vaccination.
Fixed costs also included training costs. Variable costs consisted of staff
time, supplies, and recruitment necessary to implement each strategy. With
the clinic as the primary unit of analysis, we estimated an average cost per
clinic by distributing fixed costs evenly among all clinics. Because of
variation in the number of providers at each clinic, variable average costs
were weighted on clinic resource utilization.
Variable Cost

We calculated the cost of time spent by project staff, clinic staff, and parents
receiving the program by multiplying an estimated per-minute rate
measured in US dollars by their time spent implementing tasks or
participating in the education programs. Project staff pay rates and time
available for implementation of tasks were adjusted by accounting for fringe
benefits and estimated productivity rates (Table 1). Previous studies have
used an 85% productivity rate largely based on Urban et al (1990)20. Since
mid-1990, the US has seen significant growth in the average annual labor
productivity due to capital investments in information technology along with
innovative work processes.21 A more recent analysis by Burda et al. (2015)
used the American Time Use Survey (ATUS) 2003-2012, where sample
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respondents reported spending 7% of their time at work not working.22
Hence, productivity was assumed as 93% in this analysis.
Project staff time was self-reported using logs measuring time spent
training immunization champions, maintaining clinic staff rosters, producing
quarterly A&F reports, and producing additional resources including fact
sheets and champion binders.
Clinic staff per-minute rates were estimated by averaging actual pay
rates from a sample of 120 clinical staff representing all job classifications.
Time spent by clinical staff implementing the different strategies was
collected in two ways. First, immunization champions reported the time
spent distributing and discussing the A&F reports with their peers using time
logs. Second, we captured time spent completing the online CE using
system-generated completion reports and multiplying the participants
estimated wage rate by the duration of the learning module.
Material costs were captured by multiplying the number of pages
printed for the A&F reports, training materials, and additional resources by
the cost per page and then adding additional supplies where appropriate.
Postage costs were incurred with the first two quarterly A&F reports;
however, subsequent reports were sent via TCP’s inter-institutional
mailroom at no cost to the project. Because the reminder and educational
programs were delivered electronically, material costs associated with
these strategies were not incurred.
Fixed Cost

Third-party vendors were contracted to program and implement provider
and parent reminders in the EHR and produce the mobile APP for the parent
education program. Contractors created a pediatric EHR wellness registry
on which an algorithm was applied to inform providers on patient’s HPV
vaccination status and whether any doses of HPV vaccine were due. The
same registry and algorithm were used to notify parents of their child’s HPV
vaccination status through the online patient portal. App developers
designed, tested, launched, and maintained the network-specific parent
education program on multiple mobile platforms.
Parents were required to complete an online survey to participate in
the parent education component. This contact method generated
recruitment costs of only parents eligible to receive the education
component based on the clinic they identified with. Because this analysis is
from the clinic/network perspective, parent time spent engaging in the
recruitment process was excluded. However, monetary incentives received
via an electronic gift card were included as their cost was born by the
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program to attract participants. Also included were time and mileage of
project staff incurred inviting parents to the program and visiting clinics to
actively recruit participants at clinics randomized to receive the parent
education component.
RESULTS
Program Implementation

Total program implementation costs between October 2015 and February
2018 totaled $157,534. The average cost per clinic (n=51) was $4749
weighted on clinic size and staff participation. In aggregate, the average
cost per HPV vaccination-eligible adolescent was about $1.
Quarterly A&F reports were delivered to 6 pilot clinics beginning in
February 2016 with full rollout to all clinics in May 2016 at a total cost of
$35,334 and average cost of $786 per clinic (Table 2). Costs were
categorized by personnel time spent producing and distributing the A&F
reports, material costs, and binders provided to keep each respective
clinic’s reports. Time spent by project and clinic staff producing and
distributing the A&F reports totaled $21,611 and $7935, respectively. The
cost of the packets was $4683 and $1105 for the champion binders totaling
$5788 in material costs. Average costs per clinic were $660 and $125 for
personnel time and materials, respectively. Time costs represented 84% of
the total A&F implementation cost with 73% of that representing the time
spent extracting vaccination rates from the EHR composing the reports, and
compiling them into packets for each of the 51 clinics.
A total of 221 clinical staff completed the 1-hour online course at a
total cost of $10,225 in personal time and an average of $368 per clinic
(Table 2). The largest share, $6699 (66%), resulted from 55 physicians
(25%) completing the course and having the highest wage rate. Medical
assistants (MAs) constituted the largest share of participants (92, or 42%)
at a cost of $1516 (15%). Nurses (49, or 22%) also completed the course
costing $1306 (13%). The remainder of participants were made up of a
combination of nurse practitioners, practice managers, social workers, and
other clinical support staff.
Healthcare providers and parents received automated reminders
through the EHR at a cost of $42,000 for third-party contracted services
(Table 2). The total cost was not dependent on clinic size and was divided
equally among all 51 clinics for an average cost of $824.
The parent education component cost totaled $55,228, representing
combined contracted services for producing the tailored mobile app (Table
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2). Fifty-six of the 141 parents intended for treatment utilized the mobile
education application and averaged less than a minute per parent directed
to the app. The average contract cost was $2126 per clinic receiving the
app. Including the parent recruitment cost resulted in a total cost of $63,286
at an average of $2540 per clinic.
Champion Training and Parent Recruitment

Prior to program rollouts, TCP champions, 2 from each clinic, participated
in a series of training webinars, 1 for the pilot clinics and 3 for all clinics,
hosted by UTHealth project staff. Each webinar was approximately 30
minutes and with a total training cost of $6689 (Table 2). A total of 223 TCP
staff identified as champions participated in at least 1 of 4 webinars at a
time cost of $5907, an average cost of $115 per clinic. Due to champion
turnover throughout the study period, an average of 2 webinars were
attended by each participant. The cost of hosting and administering the
training sessions was $782.
Additionally, variable recruitment costs were incurred to introduce
the parent education component. Ninety-eight parents were recruited
through the online survey at a total cost of $8058 with the largest individual
share coming from incentives paid to participants ($3525, or 44%). The
remaining $4533 (56%) resulted from recruitment activities including project
staff time and traveling to clinics, and providing recruitment printed
materials.
Sensitivity Analysis

There were 3 primary sources of variability in measured costs of program
implementation: variation in TCP champion participation and wage rates,
number of parents participating in the parent education, and the methods
for recruiting participants in the parent education component. A sensitivity
analysis was conducted using total average costs to demonstrate how costs
vary with different TCP staff and parent participation.
A&F implementation costs were estimated under different scenarios
depending on variation in TCP wage rates under the observed participation
level. The least costly and costliest scenarios assume observed champion
participation at the lowest and highest TCP wage rates--medical assistants
and physicians--that resulted in cost estimates of $633 and $807 per clinic,
respectively. These were compared to observed wage rates, or base case,
of $786 per clinic. Assuming the least costly and costliest scenarios, total
program implementation cost ranges between $151,413 and $162,747 with
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differences from the observed $157,534 of -$6121 and +$5213,
respectively.
The parent component targeted 26 clinics randomly assigned to
receive the parent education component from among the total 51 clinics.
We then used simulation to scale up the intervention to all clinics and
estimate the effect on the total average cost of the parent education.
Observed weighted average recruitment costs were imputed for the
additional clinics, resulting in an average variable cost of $360 per clinic.
Fixed costs were distributed across all 51 clinics, yielding an assumed
average fixed cost of $1082 per clinic. The total average cost of expanding
the parent component to all clinics declined from the observed $2540 to an
estimated $1443 due to broader distribution of fixed costs. Assuming
average observed cost across the additional 25 clinics, total implementation
cost increases by $10,350 to $167,884.
It is assumed recruitment costs through the parent survey would be
incurred under normal implementation. The sensitivity analysis was
expanded to consider alternate scenarios, assuming no survey was used
for recruitment as a minimum, the observed costs as the maximum, and the
midpoint to estimate a combination or alternate recruitment strategy.
Incentive cost totaled $3525. Removing this component resulted a 44%
reduction in recruitment cost to $4533 ($126 per clinic from $414).
Assuming a midpoint cost savings of $1763, recruitment costs are
estimated at $6295 ($270 per clinic). Different recruitment strategies may
have a significant effect on recruitment costs; however, in this case, total
implementation cost was reduced only about 3% to $154,009 at the
minimum and only about 1% to $155,771 at the assumed midpoint.
DISCUSSION
Implementation costs were estimated for a multicomponent strategy to
increase HPV vaccination rates in a large pediatric clinic network. A&F,
provider education, provider/parent reminders, and parent education
components were implemented at total average costs of $786, $368, $824,
and $2126, respectively, per clinic. The AVP program was delivered at a
total cost of $157,534, or $4749 per clinic. Sixty-six percent ($103,917) of
the total costs were fixed, including contracted services to produce
vaccination reminders to providers and parents and the tailored parent
education mobile app and training costs. The variable costs included
materials and personal time spent generating and distributing A&F reports
and time spent participating in the provider education program (29%,
$45,559) and recruiting parents to the AVP (5%, $8058). Future programs
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may forgo this recruitment step with the risk of drawing ineligible participants
and attracting fewer participants.
Though excluded from this clinic/network perspective, we estimated
the time spent by parents engaging with the mobile app and recruitment
activities and the cost associated with that time. Parents spent an average
of about 17 minutes, mostly completing the survey. The cost of this time
totaled $599 completing the recruitment survey and $51 utilizing the
education app. We found this cost to be minimal, only accounting for about
0.4% of the total program cost.
The analysis utilizes the network/clinic as the unit of analysis to
inform administrators about the costs associated with implementing these
system-level strategies. Previous studies examining costs of programs to
increase HPV vaccination rates and cancer screening have focused on
patients as the unit of analysis. A 2017 study compared 2 HPV vaccination
intervention strategies for Hispanic parents of daughters aged 9 to 17 years
old. The estimated per-participant cost was $88 for the print-based photo
novella method and $108 for the iPad-based tailored interactive multimedia
intervention.23 The AVP program was delivered at an estimated $1 per HPV
vaccine-eligible adolescent, highlighting the advantage of implementing in
a large clinic network and targeting providers reaching substantially more
eligible patients than other strategies. For example, over the course of this
study, 155,000 HPV vaccination-eligible adolescents were seen in TCP
clinics and 107,165 (69%) initiated the vaccine series. In 2017, about 58%
of adolescents in Texas had received one or more dose of HPV vaccine
while about 40% were up to date.24 Though observed vaccine initiation
during the study period does not meet the Healthy People 2020 goal of 80%,
it considerably outpaces Texas rates.
Even though the observed AVP costs per patient are less than those
of other intervention strategies, the sensitivity analysis shows that the level
of participation and wage rates have an effect on overall cost to the clinic
and network for implementing these strategies. Depending on who and how
many participate in the A&F component, program costs can vary from $633
to $807 per clinic, compared to the observed $786. This results in a range
of about $151,413 to $162,747 in total costs. Additionally, expanding the
parent education component to all 51 clinics reduced the per-clinic average
cost from $2540 to $1443. Because a large share of the total cost is fixed,
the overall average cost per clinic is sensitive to the number of clinics and
parents participating in the program though total program costs increase by
$10,350 when expanding across all clinics.
This study has limitations. UTHealth personnel time costs were
based on self-reported time, and TCP wage rates were based on a sample
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of actual salaries across all job descriptions. It is also possible for providers
to complete the education module outside of normal clinic hours, reducing
clinic costs, and imposing a personal time cost on the provider. Wage
information for parents was estimated based on census per-capita income
of the individuals’ zip code. Time spent by providers discussing HPV
vaccination with patients was not observed and therefore omitted from the
cost estimates.
CONCLUSION
While HPV vaccination has been shown to be a cost-effective way to
prevent HPV-related cancers25, the cost of strategies for increasing HPV
vaccination have not been determined. Provider-based strategies including
A&F, provider education, and reminders were implemented at costs of
$35,334, $10,225, and $42,000, respectively, with a complimentary parent
component introduced to a random sample of clinics costing $55,228.
Additional training and recruitment costs equaled $6689 and $8058,
respectively. Fixed costs represented the largest share (66%) of total costs,
making the results sensitive to the number of participating clinics and
parents (Figure 1). Future assessments should replicate the cost analysis
under normal operating conditions with minimal to no external support. This
research serves to inform implementation scientists and clinic and provider
network decision-makers on the costs of implementing strategies for
increasing HPV vaccination among adolescent patient populations.
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Table 1. Project Staff Wage Adjustment
Position
Base
Base
Fringe
Work
Annual Benefit
Hours
Salary
Rate
per Year
($)
(1)

Project manager
Project coordinator
Database manager
Graduate assistant

2080
2080
2080
1040

70,845
45,320
66,852
20,000

0.27
0.33
0.33
0.26

Salary
and
Fringe
(2)

89,973
60,276
88,913
25,200

Salary
per
Minute
(3)

0.72
0.48
0.71
0.40

Total
Paid
Time Off
Hours
(4)

Annual
Hours
at Work
(5)

188
176
260
40

1892
1904
1820
1000

Annual
Hours
Available
for Tasks
(6)
1760
1771
1693
930

Proportion
of Paid
Time
Available
for Tasks
(7)
0.85
0.85
0.81
0.89

Adjusted
Salary
per
Minute
(8)
0.85
0.57
0.88
0.45

(1) Institution fringe benefit rates
(2) (Base Salary * Fringe Benefit Rate) + Base Annual Salary
(3) Per-minute rate of Base Annual Salary excluding fringe benefits. 100% based on 52 wk/y and 40 h/wk. 50% based on 52 wk/y and 20 h/wk. Intern is 10
wk/y and 40 h/wk.
(4) 100% employees calculated at 8 h/day and 50% employees calculated at 4 h/day.
(5) Work hours per Year - Total Paid Time Off Hours
(6) Annual Hours at work - (Annual Hours at Work * 0.07). Calculation based on 93% productivity rate based on Burda et al.21
(7) Annual Hours Available for Work / Work Hours per Year
(8) (Salary and Fringe / Annual Hours Available for Tasks) / 60
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Table 2. Strategy Implementation Costs
Resource Input

Units

Total Program Implementation
Assessment and Feedback (A&F)
Personal time (min)
UT project staff (min)
TCP clinic staff (min)
Materials
A&F report packets (packets)
Resource packets (packets)
Champion binders (binders)
Provider Education
TCP staff time (min)
Provider Reminders
Contract services (services)
Parent Education
Mobile application (applications)
Training
Personal time
UT project staff (min)
TCP clinic staff (min)
Recruitment
UT project staff (min)
Mileage (mi)
Incentives (gift cards)
Printed materials (pages)

34,381
27,904
6477
412
51
51
13,260

700
6092
10,070
1224
141
2274

$53,617

Average
Cost per
Clinic1
$103,917 $4749

$35,334
$29,546
$21,611
$7935
$5788
$4227
$456
$1105

.
.
.
.
.
.
.
.

$786
$660
$501
$159
$125
$95
$9
$22

$10,225
$10,225
.
.
$52
.
.
.
.
.
$8058
$3423
$655
$3525
$455

.
.
$42,000
$42,000
$55,228
$55,228
$6689
$6689
$782
$5907
.
.
.
.
.

$368
$368
$824
$824
$2126
$2126
$231
$231
$116
$115
$414
$101
$8
$288
$17

Variable
Cost

Fixed
Cost

1

Assessment and Feedback, Provider Education, and Provider/Parent Reminders were implemented in 51
clinics. Parent Education was implemented in 26 clinics.
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Figure 1. Program Cost Distribution
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